TCMD logo

TCMD Stock Overview

Profile

Full Name:

Tactile Systems Technology, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

July 28, 2016

Indexes:

Not included

Website:

http://tactilemedical.com

Description:

Tactile Systems Technology, Inc. is a medical technology company that develops and supplies innovative medical devices for the treatment of chronic conditions. The company was founded in 1995 and is headquartered in Minneapolis, Minnesota. The company's mission is to help people suffering from chronic conditions live better and take care of themselves at home. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive condition that is often an unwanted side effect of cancer treatment, as well as the ACTitouch system, a medical device used to treat varicose ulcers and chronic venous insufficiency. The company's products allow for long-term treatment of chronic conditions.

Key Details

Price

$13.77

Market Cap

$324.77 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$292.98 M(+6.76% YoY)

Annual EPS

$0.70(-43.09% YoY)

PE Ratio

19.67

Annual ROE

8.27%

Annual Debt To Equity

0.12

Beta

0.88

Events Calendar

Earnings

Next earnings date:

May 6, 2025

Recent quarterly earnings:

Feb 18, 2025

Recent annual earnings:

Feb 18, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 19, 25 B. Riley Securities
Neutral
Nov 5, 24 BTIG
Neutral
Sep 26, 24 B. Riley Securities
Buy
Aug 8, 23 Oppenheimer
Outperform
May 9, 23 Piper Sandler
Overweight
May 9, 23 Oppenheimer
Outperform
Apr 17, 23 BTIG
Buy
Aug 2, 22 Piper Sandler
Overweight
Aug 2, 22 Oppenheimer
Outperform
Jul 18, 22 BTIG
Buy

Screeners with TCMD included

Companies with buyback
US stocks
High Piotroski score stocks
Biggest stock losers today
Most recommended stocks
Stocks with low RSI
Stocks below analysts price target
Healthcare sector
All stocks
High Altman Z score stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$13.77
TCMD price is $13.77

Price All-time High

$76.29
TCMD price is currently -81.95% below its historical high of $76.29

Price Analysts Target

$21.50
TCMD price is currently -35.95% lower than the consensus analysts' forecast

Price Today Change

-5.03%
TCMD price is down -5.03% today

Price YTD Change

-16.55%
TCMD price is down -16.55% since January 1st

Price 3-Year Change

-33.45%
TCMD price is down -33.45% over the past 3 years

Market cap

Market Cap

$324.77 M
TCMD market capitalization is $324.77 million

Market Cap 3-Year Change

-21.06%
TCMD market capitalization is down -21.06% over the past 3 years

Market Cap All-time High

$1.42 B
TCMD market capitalization is currently -77.20% below its historical high of $1.42 billion

Market Cap Sector Rank

61.73%
TCMD market capitalization is higher than 61.73% of companies in Healthcare sector

Technical

Beta

0.88
TCMD beta is 0.88

200-day SMA

$14.62
TCMD price is currently -5.84% below its 200-day simple moving average

14-day RSI

24.21
TCMD 14-day relative strength index is 24.21

30-day Relative Volume

0.86
TCMD 30-day relative volume is 0.86

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$292.98 M
TCMD annual revenue is $292.98 million

Annual Revenue Analysts Estimate

$318.00 M
TCMD annual revenue is currently -7.87% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+6.76%
TCMD annual revenue is up +6.76% year-on-year

Annual Revenue Sector Rank

69.02%
TCMD annual revenue is higher than 69.02% of companies in Healthcare sector

Profit

Annual Gross Profit

$216.69 M
TCMD annual gross profit is $216.69 million

Annual Gross Margin

73.96%
TCMD annual gross profit margin is 73.96%

Annual Operating Profit

$22.18 M
TCMD annual operating income is $22.18 million

Annual Operating Margin

7.57%
TCMD annual operating profit margin is 7.57%

Annual Net Income

$16.96 M
TCMD annual net profit is $16.96 million

Annual Net Margin

5.79%
TCMD annual net profit margin is 5.79%

EPS

Annual EPS

$0.70
TCMD annual earnings per share is $0.70

Annual EPS Analysts Estimate

$0.68
TCMD annual earnings per share is currently +3.70% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-43.09%
TCMD annual earnings per share is down -43.09% year-on-year

Annual EPS Sector Rank

87.91%
TCMD annual earnings per share is higher than 87.91% of companies in Healthcare sector

ROA & ROE

Annual ROA

5.85%
TCMD annual return on assets is 5.85%

Annual ROE

8.27%
TCMD annual return on equity is 8.27%

EBIT & EBITDA

Annual EBIT

$25.57 M
TCMD annual earnings before interest & taxes is $25.57 million

Annual EBITDA

$32.37 M
TCMD annual EBITDA is $32.37 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

19.67
TCMD price to earnings ratio is 19.67

PE Ratio Sector Rank

36.5%
TCMD price to earnings ratio is higher than 36.5% of companies in Healthcare sector

PB Ratio

PB Ratio

1.50
TCMD price to book ratio is 1.50

PB Ratio Sector Rank

52.72%
TCMD price to book ratio is higher than 52.72% of companies in Healthcare sector

PS Ratio

PS Ratio

1.11
TCMD price to sales ratio is 1.11

PS Ratio Sector Rank

27.38%
TCMD price to sales ratio is higher than 27.38% of companies in Healthcare sector

Enterprise value

Enterprise Value

$275.51 M
TCMD enterprise value is $275.51 million

Enterprise Value Sector Rank

61.5%
TCMD enterprise value is higher than 61.5% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

8.51
TCMD EV/EBITDA is 8.51

EV/EBITDA Sector Rank

80.97%
TCMD EV/EBITDA is higher than 80.97% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.36
TCMD annual current ratio is 4.36

Annual Quick Ratio

3.90
TCMD annual quick ratio is 3.90

Leverage

Annual Debt To Equity

0.12
TCMD annual debt to equity ratio is 0.12

Annual Interest Coverage Ratio

12.27
TCMD annual interest coverage ratio is 12.27

Risk & Stability

Piotroski F-Score

8
TCMD piotroski f-score is 8

Altman Z-Score

4.38
TCMD altman z-score is 4.38

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$297.92 M
TCMD annual total assets is $297.92 million

Annual Non Current Assets

$120.36 M
TCMD annual long term assets is $120.36 million

Annual Current Assets

$177.56 M
TCMD annual total current assets is $177.56 million

Annual Cash & Cash Equivalents

$94.37 M
TCMD annual cash & cash equivalents is $94.37 million

Equity

Annual Book Value

$216.60 M
TCMD annual book value is $216.60 million

Annual Working Capital

$136.86 M
TCMD annual working capital is $136.86 million

Liabilities

Annual Total Liabilities

$81.33 M
TCMD annual total liabilities is $81.33 million

Annual Total Long Term Liabilities

$40.62 M
TCMD annual total long term liabilities is $40.62 million

Annual Current Liabilities

$40.70 M
TCMD annual total current liabilities is $40.70 million

Annual Accounts Payable

$5.65 M
TCMD annual accounts payable is $5.65 million

Debt

Annual Total Debt

$45.11 M
TCMD annual total debt is $45.11 million

Annual Total Debt 1-Year Change

-10.45%
TCMD annual total debt is down -10.45% year-on-year

Annual Long Term Debt

$39.17 M
TCMD annual long term debt is $39.17 million

Annual Short Term Debt

$5.94 M
TCMD annual short term debt is $5.94 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$270.80 M
TCMD annual total expenses is $270.80 million

Annual Operating Expenses

$194.51 M
TCMD annual total operating expenses is $194.51 million

Annual Cost Of Goods Sold

$76.30 M
TCMD annual cost of goods sold is $76.30 million

Annual SGA

$183.14 M
TCMD annual SGA is $183.14 million

Annual D&A

$6.80 M
TCMD annual depreciation & amortization is $6.80 million

Annual Interest Expense

$2.08 M
TCMD annual interest expense is $2.08 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$40.66 M
TCMD annual cash flow from operations is $40.66 million

Annual CFO 1-Year Change

+13.39%
TCMD annual cash flow from operations is up +13.39% year-on-year

Annual CFI

-$2.50 M
TCMD annual cash flow from investing activities is -$2.50 million

Annual CFI 1-Year Change

-0.64%
TCMD annual cash flow from investing activities is down -0.64% year-on-year

Annual CFF

-$4.82 M
TCMD annual cash flow from financing activities is -$4.82 million

Annual CFF 1-Year Change

-184.19%
TCMD annual cash flow from financing activities is down -184.19% year-on-year

Free CashFlow

Annual FCF

$38.15 M
TCMD annual free cash flow is $38.15 million

Annual FCF 1-Year Change

+14.3%
TCMD annual free cash flow is up +14.3% year-on-year

CAPEX

Annual CAPEX

$2.51 M
TCMD annual capital expenditures is $2.51 million

Annual CAPEX 1-Year Change

+1.13%
TCMD annual capital expenditures is up +1.13% year-on-year

Institutional Ownership

Similar stocks

TSHA logo
Taysha Gene Therapies (TSHA)
MPLN logo
MultiPlan (MPLN)
EBS logo
Emergent BioSolutions (EBS)
TRVI logo
Trevi Therapeutics (TRVI)
GLUE logo
Monte Rosa Therapeutics (GLUE)
NNOX logo
Nano-X Imaging (NNOX)
DH logo
Definitive Healthcare (DH)
AURA logo
Aura Biosciences (AURA)
HRTX logo
Heron Therapeutics (HRTX)

FAQ

  • What is the ticker symbol for Tactile Systems Technology?
  • Does Tactile Systems Technology pay dividends?
  • What sector is Tactile Systems Technology in?
  • What industry is Tactile Systems Technology in?
  • What country is Tactile Systems Technology based in?
  • When did Tactile Systems Technology go public?
  • Is Tactile Systems Technology in the S&P 500?
  • Is Tactile Systems Technology in the NASDAQ 100?
  • Is Tactile Systems Technology in the Dow Jones?
  • When was Tactile Systems Technology's last earnings report?
  • When does Tactile Systems Technology report earnings?
  • Should I buy Tactile Systems Technology stock now?

What is the ticker symbol for Tactile Systems Technology?

The ticker symbol for Tactile Systems Technology is NASDAQ:TCMD

Does Tactile Systems Technology pay dividends?

No, Tactile Systems Technology does not pay dividends

What sector is Tactile Systems Technology in?

Tactile Systems Technology is in the Healthcare sector

What industry is Tactile Systems Technology in?

Tactile Systems Technology is in the Medical Devices industry

What country is Tactile Systems Technology based in?

Tactile Systems Technology is headquartered in United States

When did Tactile Systems Technology go public?

Tactile Systems Technology's initial public offering (IPO) was on July 28, 2016

Is Tactile Systems Technology in the S&P 500?

No, Tactile Systems Technology is not included in the S&P 500 index

Is Tactile Systems Technology in the NASDAQ 100?

No, Tactile Systems Technology is not included in the NASDAQ 100 index

Is Tactile Systems Technology in the Dow Jones?

No, Tactile Systems Technology is not included in the Dow Jones index

When was Tactile Systems Technology's last earnings report?

Tactile Systems Technology's most recent earnings report was on Feb 18, 2025

When does Tactile Systems Technology report earnings?

The next expected earnings date for Tactile Systems Technology is May 6, 2025

Should I buy Tactile Systems Technology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions